2025 EULAR update for Behçet's syndrome: 5 overarching principles and 12 recommendations by organ involvement. Colchicine first line for mucocutaneous and joint disease; apremilast or immunosuppressives such as TNFα inhibitors for refractory cases.
Guidelinen = 29 task force members
Hatemi et al. EULAR recommendations for the management of Behçet's syndrome: 2025 update